Subcutaneous implanted cardioverter-defibrillator in ventricular noncompaction, coronary artery disease and stroke

Pacing Clin Electrophysiol. 2021 Oct;44(10):1797-1801. doi: 10.1111/pace.14317. Epub 2021 Jul 24.

Abstract

Left ventricular hypertrabeculation/noncompaction (LVHT) is associated with arrhythmias. Guidelines for prevention of sudden cardiac death by implanted cardioverter-defibrillator (ICD) also apply to LVHT-patients. Right ventricular perforation by the ICD-lead is a matter of concern. Subcutaneous ICD (S-ICD) may overcome disadvantages of transvenous ICD in patients without a need for pacing therapy. We report a LVHT-patient with arterial hypertension, hyperlipidemia, coronary artery disease with an anterior-wall myocardial infarction 2004 and stroke without neurological deficits in 2018. Since ejection fraction of 33% remained unchanged despite bisoprolol, sacubitril/valsartan and spironolactone, he was treated with S-ICD for primary prevention of sudden cardiac death.

Keywords: coronary artery disease; implantable cardioverter defibrillator; left ventricular noncompaction; ventricular arrhythmia.

Publication types

  • Case Reports

MeSH terms

  • Coronary Artery Disease / complications
  • Death, Sudden, Cardiac / prevention & control*
  • Defibrillators, Implantable*
  • Electrocardiography
  • Humans
  • Hyperlipidemias / complications
  • Hypertension / complications
  • Male
  • Middle Aged
  • Myocardial Infarction / complications
  • Stroke / complications
  • Syncope / therapy*
  • Ventricular Dysfunction, Left / diagnostic imaging
  • Ventricular Dysfunction, Left / therapy*